MX9207291A - Moleculas novedosas de adn y anfitriones. - Google Patents

Moleculas novedosas de adn y anfitriones.

Info

Publication number
MX9207291A
MX9207291A MX9207291A MX9207291A MX9207291A MX 9207291 A MX9207291 A MX 9207291A MX 9207291 A MX9207291 A MX 9207291A MX 9207291 A MX9207291 A MX 9207291A MX 9207291 A MX9207291 A MX 9207291A
Authority
MX
Mexico
Prior art keywords
dna molecules
hosts
novel dna
endoplasmic reticulum
dibasic
Prior art date
Application number
MX9207291A
Other languages
English (en)
Inventor
Bhabatosh Chaudhurri
Christine Stephan
Peter Seeboth
Howard Riezman
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9207291A publication Critical patent/MX9207291A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención, se refiere a moléculas novedosas de ADN que codifican una 'endoproteasa de procesamiento dibásico', ubicada en el retículo endoplasmático, modificada, y al uso de la 'endoproteasa de procesamiento dibásico', ubicada en el retículo endoplasmático para el correcto procesamiento de polipéptidos heterólogos en anfitriones transformados.
MX9207291A 1991-12-16 1992-12-15 Moleculas novedosas de adn y anfitriones. MX9207291A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810984 1991-12-16

Publications (1)

Publication Number Publication Date
MX9207291A true MX9207291A (es) 1993-07-01

Family

ID=8208912

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207291A MX9207291A (es) 1991-12-16 1992-12-15 Moleculas novedosas de adn y anfitriones.

Country Status (17)

Country Link
US (2) US5501975A (es)
EP (1) EP0548012B1 (es)
JP (1) JP3305781B2 (es)
KR (1) KR100270283B1 (es)
AT (1) ATE157703T1 (es)
AU (1) AU667852B2 (es)
CA (1) CA2085308C (es)
DE (1) DE69222013T2 (es)
DK (1) DK0548012T3 (es)
ES (1) ES2107520T3 (es)
FI (1) FI105482B (es)
GR (1) GR3025324T3 (es)
IL (1) IL104075A (es)
MX (1) MX9207291A (es)
NO (1) NO308619B1 (es)
NZ (1) NZ245469A (es)
ZA (1) ZA929711B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9404270D0 (en) * 1994-03-05 1994-04-20 Delta Biotechnology Ltd Yeast strains and modified albumins
US5807702A (en) * 1995-02-27 1998-09-15 Abbott Laboratories Method for expressing phosphorylated recombinant human β-casein in a bacterial system
WO1996027017A1 (en) * 1995-02-27 1996-09-06 Abbott Laboratories A method for expressing modified recombinant proteins in a bacterial system
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
NZ303621A (en) * 1995-02-27 1999-04-29 Abbott Lab A plasmid contains recombinant proteins such as human beta-casein with an encoded exogenous enzyme such as human kinase capable of phosphorylating recombinant beta-casein in a bacterial system
US5710044A (en) * 1995-02-27 1998-01-20 Abbott Laboratories Plasmid for expressing phosphorylated recombinant proteins in a bacterial system
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
JP4463988B2 (ja) * 1998-11-06 2010-05-19 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子の生産方法
JP4092194B2 (ja) 2000-06-30 2008-05-28 フランダース インターユニバーシティ インスティテュート フォア バイオテクノロジー （ヴィーアイビー） ピキアパストリス（ＰｉｃｈｉａＰａｓｔｏｒｉｓ）におけるタンパク質糖鎖修飾
DE10221411B4 (de) * 2002-05-14 2004-07-08 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Rekombinantes Fowlpox-Virus
US20040117874A1 (en) * 2002-10-15 2004-06-17 Jianjun Yang Methods for accumulating translocated proteins
US7507573B2 (en) 2003-11-14 2009-03-24 Vib, Vzw Modification of protein glycosylation in methylotrophic yeast
WO2006073472A2 (en) * 2004-05-21 2006-07-13 Mo Bio Laboratories, Inc. Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
US20080082338A1 (en) * 2006-09-29 2008-04-03 O'neil Michael P Systems and methods for secure voice identification and medical device interface
US9926570B2 (en) 2013-03-06 2018-03-27 Glaxosmithkline Llc Host cells and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
US5391485A (en) * 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
JP2643968B2 (ja) * 1988-02-03 1997-08-25 サントリー株式会社 Ｋｅｘ２エンドプロテアーゼ及びその製造方法

Also Published As

Publication number Publication date
AU667852B2 (en) 1996-04-18
AU3007192A (en) 1993-06-17
DK0548012T3 (da) 1998-04-14
ATE157703T1 (de) 1997-09-15
JP3305781B2 (ja) 2002-07-24
US5501975A (en) 1996-03-26
ES2107520T3 (es) 1997-12-01
FI925678A0 (fi) 1992-12-14
EP0548012A1 (en) 1993-06-23
KR930013115A (ko) 1993-07-21
JPH06197787A (ja) 1994-07-19
EP0548012B1 (en) 1997-09-03
ZA929711B (en) 1993-06-16
DE69222013T2 (de) 1998-01-29
CA2085308A1 (en) 1993-06-17
DE69222013D1 (de) 1997-10-09
NO308619B1 (no) 2000-10-02
NO924847L (no) 1993-06-17
NO924847D0 (no) 1992-12-15
NZ245469A (en) 1995-03-28
FI925678A (fi) 1993-06-17
US5618690A (en) 1997-04-08
IL104075A (en) 2003-01-12
GR3025324T3 (en) 1998-02-27
CA2085308C (en) 2003-12-02
FI105482B (fi) 2000-08-31
KR100270283B1 (ko) 2000-11-01
IL104075A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
MX9207291A (es) Moleculas novedosas de adn y anfitriones.
FR2656800B1 (fr) Nouvelles proteines produits par les lymphocytes humains, sequence d'adn codant pour ces proteines et applications pharmaceutiques et biologiques.
ATE156838T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren 5-alpha-reduktases
DE68926714D1 (de) Kode zur Identifizierung von Dokumenten und dergleichen und Einheit zum Abtasten von magnetischen Kodes
ATE141946T1 (de) Hiv-2-virusvarianten
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
ATE158300T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-cholestan-on n als inhibitoren 5-alpha-reduktases
EP0795605A4 (en) DENAHRED LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR
MX9201571A (es) Resinas curables con agentes anti-espuma soportados en material solido.
IL117459A0 (en) DNA encoding papillomavirus type 18
DE69333249D1 (de) Neue Schimmel-Protease
ATE173764T1 (de) Lineare plasmide von pichia pastoris und fragmente davon
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
SE9002213D0 (sv) Albumin binding proteins
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DK52893D0 (da) Polypeptides, dna coding for the polypeptides, and uses thereof
DK104692D0 (da) A polypeptide, dna coding for the polypeptide, and uses thereof
DK111892D0 (da) A polypeptide, dna coding for the polypeptide, and uses thereof
ITFI930110V0 (it) Pianale per l'appoggio di materiale tessile semilavorato o simile.